Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies.
Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. The Vice President, Clinical Development will lead the design, implementation, and oversight of clinical trials for cell therapy products in oncology, and bring independent clinical and strategic direction to shape Lyell's clinical development approach and drive regulatory excellence across assigned programs.
Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies.